Table 2 Effect of multivitamin on overall survival before and after IPTW.

From: Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease

Cohort

Overall survival (Before IPTW)

Overall survival (After IPTW)

Univariate

Multivariate

Univariate

Multivariate

HR (CI 95%)

P value

HR (CI 95%)

P value

HR (CI 95%)

P value

HR (CI 95%)

P value

Entire cohort

0.85 (0.80, 0.91)

< 0.001

0.94 (0.89, 1.00)

0.040

0.94 (0.88, 1.00)

0.050

0.96 (0.90, 1.02)

0.203

No SLD

0.91 (0.82, 1.02)

0.103

-

-

0.93 (0.84, 1.04)

0.158

-

-

MASLD

0.86 (0.79, 0.93)

< 0.001

0.88 (0.81, 0.95)

0.034

0.93 (0.87, 1.00)

0.038

0.94 (0.88, 1.00)

0.039

  1. IPTW, inverse probability of treatment weighting; HR, hazard ratio; CI, confidence interval; SLD, steatotic liver disease; MASLD, metabolic dysfunction-associated steatotic liver disease.
Back to article page